2-Methylbenzoyl chloride → 2-Cyclooctyl-4,4-dimethyl-1-[(2-methylphenyl)carbonyl]-1,2-diazetidin-3-one
Reaktionsgleichung
[CH:1]1([N:9]2[C:12](=[O:13])[C:11]([CH3:15])([CH3:14])[NH:10]2)[CH2:8][CH2:7][CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[CH3:16][C:17]1[CH:25]=[CH:24][CH:23]=[CH:22][C:18]=1[C:19](Cl)=[O:20]>>[CH:1]1([N:9]2[C:12](=[O:13])[C:11]([CH3:15])([CH3:14])[N:10]2[C:19]([C:18]2[CH:22]=[CH:23][CH:24]=[CH:25][C:17]=2[CH3:16])=[O:20])[CH2:8][CH2:7][CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1Komponenten
3
Versuchsvorschrift
2-Cyclooctyl-4,4-dimethyl-1,2-diazetidin-3-one and 2-methylbenzoyl chloride were used for a similar reaction and treatment as Example 96, and the title compound was obtained as a white crystalline powder.
Quellen und Nachweise
- ORD-Eintrag
- ord-64524f5530c2436fad19e8ff36ca96f5
- Quelldatensatz
- uspto-grants-2012_08